Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02589496
Brief Title: Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecular Subtypes Through Integrative Genomic Analysis

First Submitted : October 27, 2015
First Submitted that Met QC Criteria : October 27, 2015
First Posted : October 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : December 9, 2020
Last Update Posted : December 14, 2020